Multikinase inhibitors

Pfizer CRZ 250 Pill - pink capsule-shape

Generic Name: crizotinib

Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc.

Xalkori is used in the treatment of Non-Small Cell Lung Cancer; Inflammatory Myofibroblastic Tumors; Lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Xalkori (Crizotinib [ kriz-oh-ti-nib ])-Pfizer CRZ 250-250 mg-Pink-Capsule-shape
Xalkori (Crizotinib [ kriz-oh-ti-nib ])-Pfizer CRZ 250-250 mg-Pink-Capsule-shape

Xalkori
Generic Name: crizotinib [ kriz-oh-ti-nib ]
Imprint: Pfizer CRZ 250
Strength: 250 mg
Color: Pink
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-8140
Inactive Ingredients: Silicon dioxide, Microcrystalline cellulose, Calcium phosphate dibasic anhydrous, Magnesium stearate, Titanium dioxide, Ferric oxide red, Shellac, Propylene glycol, Ammonia, Potassium hydroxide, Ferrosoferric oxide,
Latest News
Related Drugs